Unknown

Dataset Information

0

Antagonizing midkine accelerates fracture healing in mice by enhanced bone formation in the fracture callus.


ABSTRACT: BACKGROUND AND PURPOSE:Previous findings suggest that the growth and differentiation factor midkine (Mdk) is a negative regulator of osteoblast activity and bone formation, thereby raising the possibility that a specific Mdk antagonist might improve bone formation during fracture healing. EXPERIMENTAL APPROACH:In the present study, we investigated the effects of a monoclonal anti-Mdk antibody (Mdk-Ab) on bone healing using a standardized femur osteotomy model in mice. Additional in vitro experiments using chondroprogenitor and preosteoblastic cells were conducted to analyse the effects of recombinant Mdk and Mdk-Ab on differentiation markers and potential binding partners in these cells. KEY RESULTS:We demonstrated that treatment with Mdk-Ab accelerated bone healing in mice based on increased bone formation in the fracture callus. In vitro experiments using preosteoblastic cells showed that Mdk-Ab treatment abolished the Mdk-induced negative effects on the expression of osteogenic markers and Wnt/?-catenin target proteins, whereas the differentiation of chondroprogenitor cells was unaffected. Phosphorylation analyses revealed an important role for the low-density lipoproteinLDL receptor-related protein 6 in Mdk signalling in osteoblasts. CONCLUSIONS AND IMPLICATIONS:We conclude that Mdk-Ab treatment may be a potential novel therapeutic strategy to enhance fracture healing in patients with orthopaedic complications such as delayed healing or non-union formation.

SUBMITTER: Haffner-Luntzer M 

PROVIDER: S-EPMC4919577 | biostudies-literature | 2016 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Antagonizing midkine accelerates fracture healing in mice by enhanced bone formation in the fracture callus.

Haffner-Luntzer Melanie M   Heilmann Aline A   Rapp Anna Elise AE   Roessler Robin R   Schinke Thorsten T   Amling Michael M   Ignatius Anita A   Liedert Astrid A  

British journal of pharmacology 20160529 14


<h4>Background and purpose</h4>Previous findings suggest that the growth and differentiation factor midkine (Mdk) is a negative regulator of osteoblast activity and bone formation, thereby raising the possibility that a specific Mdk antagonist might improve bone formation during fracture healing.<h4>Experimental approach</h4>In the present study, we investigated the effects of a monoclonal anti-Mdk antibody (Mdk-Ab) on bone healing using a standardized femur osteotomy model in mice. Additional i  ...[more]

Similar Datasets

| S-EPMC4406871 | biostudies-literature
| S-EPMC10432554 | biostudies-literature
| S-EPMC4139970 | biostudies-literature
| S-EPMC4206514 | biostudies-literature
| S-EPMC2904482 | biostudies-literature
2013-10-25 | E-GEOD-51686 | biostudies-arrayexpress
| S-EPMC7700777 | biostudies-literature
| S-EPMC4640972 | biostudies-literature
| S-EPMC4363594 | biostudies-literature
| S-EPMC6385606 | biostudies-other